Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Q2SI
|
||||
| Former ID |
DNC013020
|
||||
| Drug Name |
4-(4-chlorobenzyl)phthalazin-1(2H)-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528062] | ||
| Formula |
C15H11ClN2O
|
||||
| Canonical SMILES |
C1=CC=C2C(=C1)C(=NNC2=O)CC3=CC=C(C=C3)Cl
|
||||
| InChI |
1S/C15H11ClN2O/c16-11-7-5-10(6-8-11)9-14-12-3-1-2-4-13(12)15(19)18-17-14/h1-8H,9H2,(H,18,19)
|
||||
| InChIKey |
NLXGCQIEVZYDRS-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Alpha-1D adrenergic receptor | Target Info | Inhibitor | [528062] | |
| Alpha-1A adrenergic receptor | Target Info | Inhibitor | [528062] | ||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | Alpha adrenergic receptor signaling pathway | ||||
| References | |||||